“Long Haulers” to the Rescue? Barrage of Covid-19 Media Stories, Studies and Registries Spells Hope for ME/CFS
Media Barrage A veritable avalanche of stories – the C19Recovery Awareness website provides a link to approximately 50 articles since June 1st – have highlighted the problems that many people have had recovering from the coronavirus. With eight stories...
From Fight/Flight to Neuroinflammation: Explaining the “Functional Pain” in Fibromyalgia and ME/CFS?
Sustained Stimulation of β2- and β3-adrenergic Receptors Leads to Persistent Functional Pain and Neuroinflammation. Xin Zhang, MD, PhD, Jane E. Hartung PhD, […], and Andrea G. Nackley PhD, PhD. Brain Behav Immun 2018 Oct;73:520-532. doi:...
Epic Attempt: Will EpicGenetics Transform Fibromyalgia Diagnostics and Treatment? (And Why People with ME/CFS Should Care)
EpicGenetics – a biotech firm in Los Angeles – is attempting an FM trifecta: produce a blood and genomic test and provide a treatment. EpicGenetics is trying to make a big splash in fibromyalgia. A Los Angeles biotech firm, they focused on producing...
Solid Ground at Last? Cytokines Make Good in Major ME/CFS Review
Cytokines have been like a mirage in the desert for ME/CFS. These powerful immune factors seem like they must play a major role in this disease, but as soon as researchers have closed in on them, they’ve always seemed to slip away. A recent major review from the...
New Pathways: A Step Towards Fine-Tuning Treatments for ME/CFS?
A recent Klimas/Broderick study had a lot of interesting things in it: the gender divide, and the illumination of possibly key immune and metabolic factors, but the most intriguing thing about the study was its potential precision. The study possibly identified...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
